# Scottish Investment Bank

> Scottish Investment Bank is a VC fund backing Software and Biotechnology. See 226 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Glasgow, United Kingdom
- Total investments: 226
- Last investment: Aug 2023
- Lead investor: 12%
- Last fund: Aug 2015
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/scottish-enterprise
- Website: https://www.scottish-enterprise.com/our-organisation/about-us/who-we-work-with/scottish-investment-bank

Scottish Investment Bank is a VC fund in Glasgow focused on Software and Biotechnology. They help companies to identify appropriate sources of finance, engage with funders and secure the investment they need to grow their business.They work closely with their portfolio companies to strengthen their management teams, make connections and accelerate growth.Their work also involves aiming to increase the supply of finance forbusinesses in Scotland. they want to help Scottish SMEs with growth and export potential to get this finance.Apart from supporting Scottish businesses, they also work with UK and international investors. This includes working with business angels, angel syndicates, venture capital groups and corporate investors.They operate across Scotland in partnership with Highlands and Islands Enterprise. Because their work supports and stimulates the SME funding market in Scotland, what they do supports the delivery of the Scottish Enterprise business plan.

## Contacts

5 contacts available for Scottish Investment Bank. Shizune tracks 3 team members at Scottish Investment Bank. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/scottish-investment-bank?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $327k–$3.1M |
| Series A | $1.6M–$7.5M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 32 | 14% |
| Biotechnology | 28 | 12% |
| Health Care | 25 | 11% |
| Information Technology | 24 | 11% |
| Medical | 11 | 5% |

167 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Funding Round | 55 | 24% |
| Seed | 36 | 16% |
| Series A | 32 | 14% |
| Venture - Series Unknown | 18 | 8% |
| Series B | 9 | 4% |

13 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United Kingdom | 116 | 51% |
| United States | 7 | 3% |
| France | 2 | 1% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Crawford Gillies | Chairman | 0 | https://shizune.co/investors/profile/crawford-gillies |
| Jeremy Peat | Enterprise Board | 0 | https://shizune.co/investors/profile/jeremy-peat |
| Susan Armes | Head of the Scottish Investment Bank | 60 | https://shizune.co/investors/profile/kerry-sharp |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| IOTech | The growth in IoT is explosive, impressive and unsustainable under current architectural approaches. Many IoT deployments face challenges related to latency, network bandwidth, reliability and security, which cannot be addressed in cloud-only models. |  | Venture - Series Unknown | Aug 29, 2023 |  |
| Bio-Images Drug Delivery | BDD is a specialist drug formulation company providing expertise across all areas of drug delivery. We offer a full service package to fit individual needs from troubleshooting, formulation development, in vitro and in vivo testing.Our patented time release technology OralogiK provides unrivaled control of drug release at the right place andtime. OralogiK has been validated in numerous clinical studies, enables the oral delivery of single, multi-dose or combination drugs at pre-determined times between one and 12 hours after being swallowed by the patient. This facilitates such benefits as: night time dosing of a drug to be delivered pre-wakeup multi-phased delivery of one or more drugs (immediate and delayed) to allow once-a-day dosing or for pre-treatment by one drug before the delivery of a second delivery of drugs to a specific regions of the digestive system (e.g. the colon) BDD also specialize in gamma scintigraphy, a powerful and versatile technology used to investigate the in vivo behaviour of your formulation. Coupled with pharmacokinetic data, this technique can be used to provide information on time /site of disintegration, gastric emptying, GI transit and intra/ inter individual differences.Our clinical division provides a full clinical package, including protocol development, study documentation design and regulatory authority submission, through to close out and production of ICH GCP-compliant clinical study report. | $2.5M | Venture - Series Unknown | Aug 16, 2023 |  |
| Administrate | Administrate is a comprehensive, configurable training management platform that helps organizations streamline enterprise learning and development. Organize, deliver, plan, automate, analyze, and scale your training program effectively -- all through one system. Deliver multi-modality learner experiences, maximize training resources, anddemonstrate business results with insight-rich reporting. Hundreds of organizations serving millions of learners choose Administrate to manage their training program. | $6.5M |  | Jul 11, 2023 |  |
| Causeway Therapeutics | A bio pharmaceutical spin out emerging from the University of Glasgow, working in the orthobiologic therapeutic space. Intellectual property has been generated via academic research demonstrating a proven mechanistic reasoning for the use of a microRNA therapy in the treatment of tendinopathies. | $10.5M | Venture - Series Unknown | Feb 22, 2023 |  |
| Shot Scope | Shot Scope's statistic collecting technology is currently in development, led by a team of engineers and golfers based in Edinburgh, United Kingdom. Trials are planned on UK golf courses throughout 2015 with general release scheduled for 2016. | $3.3M | Series A | Dec 13, 2022 |  |
| Speech Graphics | Speech Graphics delivers pioneering facial animation technology to the entertainment industry, working with clients such as Warner Brothers and Def Jam Recordings. Based on over 20 years of R&D in speech technology and procedural facial dynamics, our software produces high-quality facial animation from audio alone, with no need for motioncapture. Speech Graphics spun out of the University of Edinburgh’s world-renowned School of Informatics in 2010 under the leadership of founders Michael Berger and Gregor Hofer, and game industry veteran Colin Macdonald.Speech Graphics has won several awards for its speech-driven animation technology, including the prestigious John Logie Baird Award for innovation, an LT-Innovate Award, a Santander Entrepreneurial Award, and game industry awards including a 2015 Develop Award for Best Creative Outsourcer and 2015 TIGA Award for Best Animation Supplier. The company has also received several development grants, including grants from Scottish Enterprise and the University of Abertay. | $7M | Series A | Feb 23, 2022 |  |
| ENOUGH | ENOUGH is a technology spin-out company from the University of Strathclyde established to develop and commercialise novel patented technology which transforms the production economics for the meat-free food product mycoprotein by integrating the production within existing bio-refinery operations producing bio-ethanol and animal feed (DDGS). Thisgives integrated fermentation production of Food, Fuel and Feed. ​ | $49.9M | Series B | Jun 20, 2021 |  |
| Boundary | Boundary Technologies Ltd is a revolutionary new way to protect your home and family. Offering 'security as a service', the Boundary home security system will be accurate enough to provide an automatic police response and will also be the only truly smart alarm system to meet UK and European alarm standards. | $5.2M | Seed | May 26, 2021 |  |
| Red61 | Red61 has grown out of a desire to build a different kind of ticketing solution supplier. Frustrated with the state of the ticketing market and the seemingly endless cycle of dissatisfied ticketing organisations moving to new suppliers, Red61 founders, Box Office Manager Tony Davey and software designer Peter McNaught got together to create acompany whose guiding principle is to create long term collaborative relationships with its clients. | $1.8M |  | May 18, 2021 |  |
| Red61 | Red61 has grown out of a desire to build a different kind of ticketing solution supplier. Frustrated with the state of the ticketing market and the seemingly endless cycle of dissatisfied ticketing organisations moving to new suppliers, Red61 founders, Box Office Manager Tony Davey and software designer Peter McNaught got together to create acompany whose guiding principle is to create long term collaborative relationships with its clients. | $2M | Seed | May 18, 2021 |  |

10 of 226 investments shown.

## Co-investors
- [Par Equity](https://shizune.co/investors/profile/par-equity) — VC Fund, 81 deals together
- [Equity Gap](https://shizune.co/investors/profile/equity-gap) — VC Fund, 41 deals together
- [Archangels](https://shizune.co/investors/profile/archangel-informal-investments-limited) — VC Fund, 32 deals together
- [Old College Capital](https://shizune.co/investors/profile/old-college-capital) — VC Fund, 20 deals together
- [TRICAPITAL](https://shizune.co/investors/profile/tweed-renaissance-investors-capital) — VC Fund, 18 deals together
- [Mercia Fund Managers](https://shizune.co/investors/profile/mercia-fund-management) — VC Fund, 11 deals together

## Similar investors

### Similar industry
- [SVG Ventures](https://shizune.co/investors/profile/svg-ventures) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Omnivore](https://shizune.co/investors/profile/omnivore-partners) — VC Fund

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

### Similar country
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [Fuel Ventures](https://shizune.co/investors/profile/fuel-ventures-fund) — VC Fund
- [Business Growth Fund](https://shizune.co/investors/profile/business-growth-fund) — VC Fund

## Featured in investor lists
- [All Investors in Europe](https://shizune.co/investors/investors-europe)
- [All VC Funds in Europe](https://shizune.co/investors/vc-funds-europe)
- [All Investors in United Kingdom](https://shizune.co/investors/investors-united-kingdom)
- [All VC Funds in United Kingdom](https://shizune.co/investors/vc-funds-united-kingdom)
- [SaaS Investors in Europe](https://shizune.co/investors/saas-investors-europe)
- [SaaS VC Funds in Europe](https://shizune.co/investors/saas-vc-funds-europe)

## FAQ

### What does Scottish Investment Bank invest in?

Scottish Investment Bank invests primarily in Software, Biotechnology and Health Care startups, most often at Funding Round and Seed stage. Most of the 226 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Scottish Investment Bank's check size?

Scottish Investment Bank typically joins rounds of $327k–$3.1M at Seed and $1.6M–$7.5M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Scottish Investment Bank participates in.

### How do I contact Scottish Investment Bank?

Public channels for Scottish Investment Bank include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Scottish Investment Bank?

The team at Scottish Investment Bank includes Crawford Gillies (Chairman), Jeremy Peat (Enterprise Board) and Susan Armes (Head of the Scottish Investment Bank). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co